Chief Pharmaceutical Inspectorate

Back

Internal Control and Compliance Management Department

  • exercising substantive supervision over Voivodeship Pharmaceutical Inspectors, including planned and ad hoc inspections in Voivodeship Inspectorates, examining complaints concerning the activities of Voivodeship Pharmaceutical Inspectors, as well as preparing position papers and reports regarding the activities of Voivodeship Pharmaceutical Inspectors;
  • providing advisory services and evaluating risk, including confirmation that internal procedures created or modified within the Chief Pharmaceutical Inspectorate and Voivodeship Pharmaceutical Inspectorates remain in compliance with applicable laws;
  • identifying areas exposed to irregularities and taking appropriate actions in this area;
  • supervising the design and enforcement of regulations regarding conflicts of interest among employees of the State Pharmaceutical Inspection;
  • cooperating with law enforcement agencies, special services, and the Spokesperson for Public Finance Discipline, including coordinating the interaction of organizational units of the Chief Pharmaceutical Inspectorate with these bodies and participating in proceedings initiated by these bodies;
  • coordinating matters concerning inspections of the activities of the Chief Pharmaceutical Inspectorate conducted by the Supreme Audit Office, Managing Authorities, the Audit Authority, the European Commission, the European Court of Auditors, and the Public Procurement Office;
  • coordinating and conducting internal control;
  • monitoring and coordinating work regarding prevention of corruption, the effectiveness of applied anti-corruption practices, and cooperation in this regard with government administration and non-governmental organizations;
  • conducting internal audits within the Chief Pharmaceutical Inspectorate;
  • coordinating tasks related to management control and performing systematic assessment of management control, including preparing aggregate information on significant risks and weaknesses, as well as proposed improvements to management control.
{"register":{"columns":[]}}